Eden has allowed me to remember who I used to be." I'm really thankful for what Eden has been able to unlock for me." I have been able to just live my life without thinking about food." Individual results may vary
Persistent symptoms may indicate a need for dose adjustment or exploration of an alternative GLP-1 medication
Previous GLP-1 medication experience People transitioning from semaglutide or tirzepatide to retatrutide may experience different onset patterns than treatment-naive individuals
We still cant draw strong conclusions from two case reports, but the pattern is worth noting for a population that already tends to have issues with muscle function and fatigue
644 Interestingly, the mRNA expression of ZnT8, a transporter closely tied to insulin secretion and hence diabetic conditions, displayed considerable variability
J Comp Physiol Psychol 84(3):488495 Gutzwiller JP, Drewe J, Gke B, Schmidt H, Rohrer B, Lareida J et al (1999) Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2